Perampanel inhibits calcitonin gene-related peptide release from rat brainstem in vitro.

Here we provided preliminary in vitro evidence suggesting that perampanel might control pain transmission under conditions of activated trigeminal system, in a preclinical model mimicking the pathophysiology of human migraine.